Newman Dignan & Sheerar Inc’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
Newman Dignan & Sheerar Inc's LLY Position: Q2 2026 in Review
Newman Dignan & Sheerar Inc increased its Eli Lilly (LLY) stake by 0.77% in Q2 2026, buying an estimated $8.17K and bringing the position to 1,043 shares worth $1.25M. The position accounts for 0.24% of the portfolio, ranked #73.
Newman Dignan & Sheerar Inc first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. 1,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Newman Dignan & Sheerar Inc held 1,043 shares of Eli Lilly worth $1.25M as of Q2 2026.
- Newman Dignan & Sheerar Inc bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
- Eli Lilly made up 0.24% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #73 holding.
- Newman Dignan & Sheerar Inc first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
- 1,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.